Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
N. Hattori, T. Ishihara, K. Ikekubo, K. Moridera, M. Hino, H. Kurahachi.
Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia.
J Clin Endocrinol Metab, 75 (1992), pp. 1226-1229
[2.]
V. Leite, H. Cosby, L.G. Sobrinho, A. Fresnoza, M.A. Santos, G. Freisen.
Characterization of big big prolactin in patients with hyperprolactinemia.
Clin Endocrinol, 37 (1992), pp. 365-372
[3.]
R.R. Gala.
Prolactin and growth hormone in the regulation of immune system.
Proc Soc Exp Biol Med, 198 (1991), pp. 513-527
[4.]
G. Lindstedt.
Endogenous antibodies against prolactin – a “new” cause of hyperprolactinemia.
Eur J Endocrinol, 130 (1994), pp. 429-432
[5.]
B. Cavaco, V. Leite, A. Santos, E. Arranhado, L.G. Sobrinho.
Some forms of big big prolactin behave as a complex of monomeric prolactin with and immunoglobulin G in patients with macroprolactinemia or prolactinoma.
J Clin Endocrinol Metab, 80 (1995), pp. 2342-2346
[6.]
N. Hattori, C. Inagaki.
Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: Bioassay and clearance studies of PRL-Immunoglobulin G complex.
J Clin Endocrinol Metab, 82 (1997), pp. 3107-3110
[7.]
N. Hattori.
The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
J Clin Endocrinol Metab, 81 (1996), pp. 586-590
[8.]
D. Pascoe-Lira, G. Duran-Reyes, I. Contreras-Hernández, L. Manuel-Apolinar, F. Blanco-Favela, A. Leaños-Miranda.
Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women.
J Clin Endocrinol Metab, 86 (2001), pp. 924-929
[9.]
A.T. Guay, P. Sabharwal, S. Varma, W.B. Malarkey.
Delayed diagnosis of psychological erectile dysfunction because of the presence of macroprolactinemia.
J Clin Endocrinol Metab, 81 (1996), pp. 2512-2514
[10.]
K. Miyai, K. Ichihara, K. Kondo, S. Mori.
Asymptomatic hyperprolactinemia and prolactinoma in the general population. Mass screening by paired assays of serum prolactin.
Clin Endocrinol, 25 (1986), pp. 549-554
[11.]
S. Vallette-Kasic, I. Morange-Ramos, A. Selim, G. Gunz, S. Morange, A. Enjalbert, et al.
Macroprolactinemia revisited: A study on 106 patients.
J Clin Endocrinol Metab, 87 (2002), pp. 581-588
[12.]
A.O. Olukoga, J.W. Kane.
Macroprolactinemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
Clinical Endocrinology, 51 (1999), pp. 119-126
[13.]
J.H. Vieira, T.T. Tachibana, L.H. Obara, R.M. Maciel.
Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia.
Clin Chem, 44 (1998), pp. 1758-1759
[14.]
M.N. Fahie-Wilson.
Polyethylene glycol precipitation as a screening method for macroprolactinemia.
Clin Chem, 45 (1999), pp. 436-437
[15.]
H. Leslie, C.H. Courtney, P.M. Bell, D.R. Hadden, D.R. McCance, P.K. Ellis, et al.
Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
J Clin Endocrinol Metab, 86 (2001), pp. 2743-2746
Copyright © 2003. Sociedad Española de Endocrinología y Nutrición
